Eltrombopag To Reduce The Need For Platelet Transfusion In Subjects With Chronic Liver Disease And Thrombocytopenia Undergoing Elective Invasive Procedures
- Status
- TERMINATED
- Phase
- PHASE3
Clinical Trials Related to Thrombocytopenia
Related studies linked through entity extraction aliases.
Romiplostim Treatment of Thrombocytopenia in Subjects With Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)
- Status
- COMPLETED
- Phase
- PHASE2
Using Whole-Person-Care Guide in Patients Receiving Care for Cancer or Complications From Cancer Treatment
- Status
- COMPLETED
- Phase
- NA
Evaluating the Presence of Blood Clots in People With Heparin-Induced Thrombocytopenia (HIT) (The HOT Study)
- Status
- TERMINATED
- Phase
- N/A
Thrombopoietin Levels and Platelet Transfusion in Neonates
- Status
- COMPLETED
- Phase
- N/A
An Open Label Study of Romiplostim in Adult Thrombocytopenic Subjects With ITP
- Status
- COMPLETED
- Phase
- PHASE3
Aspirin in Patients With Myocardial Infarction and Thrombocytopenia
- Status
- TERMINATED
- Phase
- PHASE3
Evaluating the Safety of Long Term Dosing of Romiplostim (Formerly AMG 531) in Thrombocytopenic Subjects With Myelodysplastic Syndromes (MDS)
- Status
- COMPLETED
- Phase
- NA
Pharmacokinetics in Patients With Newly Diagnosed High-Grade Glioma Receiving Temozolomide and Radiation Therapy
- Status
- TERMINATED
- Phase
- N/A
Retrospective & Prospective Observational Study of Patients With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
- Status
- COMPLETED
- Phase
- N/A
Strategies for Transfusion of Platelets (SToP)
- Status
- TERMINATED
- Phase
- PHASE3
A Safety and Efficacy Study to Evaluate AMG 531 Treatment in Subject With Myelodysplastic Syndrome Receiving Revlimid
- Status
- COMPLETED
- Phase
- PHASE2
Romiplostim (AMG 531) Versus Medical Standard of Care for Immune (Idiopathic) Thrombocytopenic Purpura
- Status
- COMPLETED
- Phase
- PHASE3
Dose/ Schedule Finding Trial of Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT) in Non-Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE2
Mechanism of Thrombocytopenia in Infants
- Status
- COMPLETED
- Phase
- N/A
Determination of Safe and Effective Dose of Romiplostim (AMG 531) in Subjects With Myelodysplastic Syndrome (MDS)Receiving Hypomethylating Agents
- Status
- COMPLETED
- Phase
- PHASE2
Busulfan, Antithymocyte Globulin, and Fludarabine Followed By a Donor Stem Cell Transplant in Treating Young Patients With Blood Disorders, Bone Marrow Disorders, Chronic Myelogenous Leukemia in First Chronic Phase, or Acute Myeloid Leukemia in First Remission
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Determination of Safe Dose of Romiplostim (AMG 531) in Patients With Myelodysplastic Syndromes (MDS)
- Status
- COMPLETED
- Phase
- PHASE2
A Dose and Schedule Finding Trial With AMG 531 for Chemotherapy Induced Thrombocytopenia (CIT) in Adults With Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety and Performance of MIRASOL® PRT Treated Platelet Transfusion Products
- Status
- COMPLETED
- Phase
- EARLY_PHASE1